Cardiovascular risk factors and metabolic parameters in hypertensive women
DOI:
https://doi.org/10.24959/cphj.14.1330Keywords:
cardiovascular risk factors, metabolic indicators, arterial hypertension, women, ageAbstract
Prevalence of arterial hypertension (AH) in women increases with age. One of the reasons for that is a menopause preceding the endocrinal disbalance that is responsible for growing incidence of the cardiovascular pathology. In the current study we determined modified factors of the cardiovascular risk and revealed peculiarities of metabolic indicators in hypertensive women depending on the age. We observed 220 hypertensive women at age from 30 to 79 years (the average age was 54.25±0.40 years old) that were divided into 5 groups according to their age. Group 1 (30-39 years old) included 12 women, group 2 (40-49 years old) – 55 women, group 3 (50-59 years old) – 90 women, group 4 (60-69 years old) – 53 women and group 5 (70 years and older) – 10 women. The major modified factors of the cardiovascular risk, anthropometric parame-ters, indicators of glucose and lipid metabolism have been determined and the comparative analysis of the data obtained has been performed. It has been found that the lack of physical exercises, chronic stress and salt overuse were the major factors of the cardiovascular risk in hypertensive women. Worsening of anthropometric parameters was associated with increasing age, deterioration of indicators of lipid and glucose metabolism – with progression of obesity, general (according to the body mass index) and central (according to the waist circumference) ones.
References
Давыдова И.В. // Укр. мед. вісник. – 2006. – №9. – С. 44-48.
Alberti K.G., Sbaw J., Zimmet P. // Lancet. – 2005. – Vol. 366. – Р. 1059-1062.
Atsma F., Bartelink M., Grobbee D.E. et al. // Menopause. – 2006. – Vol. 13. – Р. 265-279.
Bromlage P., Pittrow D., Wittchen H.U. et al. // Am. J. Hypertens. – 2004. – Vol. 17. – P. 904-910.
Carriere L., Dopuy A.M., Scali J. et al. // Climacteric. – 2008. – Vol. 11. – P. 74-83.
Casiglia E., Mormino P., Tikhonoff V. et al. // J. Hypertens. – 2002. – Vol. 20, Suppl. 2. – P. S17-S22.
Cifkova R., Lejskova M., Pitha I. et al. // J. Hypertens. – 2008. – Vol. 26. – P. 1976-1982.
Coylewright M., Reckelhoff J.F., Ouyang P. // Hypertens. – 2008. – Vol. 51. – P. 952-959.
Franklin S.S. // J. Hypertens. – 2002. – Vol. 20, Suppl. 2. – P. 3-5.
Friedewald W.T., Fredrickson D.S., Levy R.I. // Clin. Chem. – 1972. – Vol. 18. – P. 449-502.
Wajchenberg B.L. // Endocrin. Rev. – 2000. – Vol. 21. – P. 697-738.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
